Arcadia Biosciences, Inc. — Director's Dealing 2018

Sep 21, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-09-18

Reporting Person: Reiter Sarah (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-18	Stock Option (Right to Buy)	$4.63	A	38400	Acquired	2028-09-18	Common Stock (38400)	Direct

Footnotes

F1: The options will vest monthly in equal installments over a period of two years from the date of the grant, subject to the Participant's continued service.